Please ensure Javascript is enabled for purposes of website accessibility

Why Aphria Is Tanking Again Today

By Keith Speights - Dec 4, 2018 at 11:17AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The fallout continues from a controversy over the Canadian marijuana grower's Latin American acquisitions.

What happened

Shares of Aphria (APHA) plunged 20.5% as of 10:38 a.m. EST on Tuesday, marking the second consecutive day of declines of greater than 20%. The Canadian marijuana stock fell sharply on Monday after a short-seller alleged that Aphria insiders bought stakes in "virtually worthless corporate entities overseas" then led Aphria to acquire these international companies at unjustifiably high prices.

Tuesday's big drop was an extension of the sell-off that began because of the allegations. The free fall continued even though Aphria released a public statement that the company "unequivocally stands behind" its recent acquisitions of Latin American businesses.

Marijuana growing in a greenhouse

Image source: Getty Images.

So what

The allegations against Aphria are serious. Investors should be troubled -- and livid -- if Aphria insiders deliberately guided the company to significantly overpay for acquisitions that would deliver little value to shareholders. And that's what Gabriel Grego, his Quintessential Capital Management hedge fund, and forensic analysis firm Hindenburg Research are alleging happened.

However, Aphria disputes these allegations. The company stated in a press release that its board of directors received advice from an independent and qualified financial advisor about the valuations of the acquisitions of the Latin American operations that it acquired from SOL Global Investments (formerly Scythian Biosciences). Aphria also maintained that the purchase price was in line with Latin American deals made by some of its peers.

Furthermore, Aphria said that its representatives conducted due diligence by meeting with the management teams of the Latin American businesses and visiting sites. The company added that it retained legal counsel "who completed extensive legal due diligence on the assets, licenses, and businesses in each jurisdiction." 

Aphria disclosed in the press release announcing the Latin American acquisition transaction that some insiders in the company owned "a de minimis amount of shares and warrants of SOL." This is the second time that Aphria insiders owned a stake in a company with which Aphria conducted a significant financial transaction. Aphria executives came under fire earlier this year because some of them owned stakes in Nuuvera prior to Aphria's acquisition of the company

Now what

While a sell-off over a potential scandal is to be expected, such sell-offs can also be overdone. Aphria has already lost a lot more in market cap than the total value of its controversial acquisitions. It's likely that the stock could bounce back if no further damaging revelations emerge.

Perhaps the biggest impact of the recent allegations, though, is that they could hurt Aphria's prospects of landing a partnership with a major company outside of the cannabis industry. Investors might want to look elsewhere until the dust settles with Aphria's latest controversy. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
338%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.